Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 April, 2024 17:21 IST
Accumulate Infosys; target of Rs 1,554: IDBI Capital
Source: IRIS | 14 Jan, 2021, 11.06AM
Rating: NAN / 5 stars.
Comments  |  Post Comment

Infosys' (INFO) had another quarter of an all-round beat to ours and consensus forecast. Q3FY21 revenue grew by 5.3% QoQ in CC and 6.2% QoQ in USD vs. our forecast +2.4% in CC. EBIT margin improved by 7bps QoQ to 25.4% vs. our forecast of 24.6%. EPS of Rs12.2, +7.2%/+16.5% QoQ/YoY was also a beat to our forecast, said IDBI Capital Markets & Securities.

Q3FY21 saw an all-time high large-deal TCV of USD 7.13 billion (net-new being ~73%). Further, the increase in FY21 guidance was also a beat. INFO has now guided for CC revenue growth of 4.5-5% vs. 2-3% earlier and EBIT margin of 24-24.5% vs. 23-24%. Further, it is confident of a double-digit revenue growth in FY22.

Commenting on the Infosys Q3 review, IDBI Capital said, "We factor the beat in Q3FY21, TCV & outlook for deal pipeline, FY21 guidance revision and increase FY21/22/23 revenue (in USD) by 2.8%/4.8%/4.6% and EPS by 4.1%/4.6%/4.8. We now forecast revenue/EPS CAGR of 12.3%/13.9% over FY21-23E. Given strong growth and RoE of 30%+ we increase our target PER to 26x (vs. 30x for TCS) from 23x earlier. We now recommend Accumulate with new target price of Rs 1,554."

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.



 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer